1IA
PFE icon

1834 Investment Advisors’s Pfizer PFE Stock Holding History

1834 Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.98M Buy
289,830
+2,135
+0.7% +$55.8K 0.79% 32
2026
Q1 		$8.08M Buy
287,695
+9,408
+3% +$250K 1.01% 29
2025
Q4 		$6.93M Sell
278,287
-26,812
-9% -$676K 0.87% 32
2025
Q3 		$7.77M Buy
305,099
+7,334
+2% +$181K 0.95% 28
2025
Q2 		$7.22M Buy
297,765
+23,360
+9% +$545K 0.91% 34
2025
Q1 		$6.95M Buy
274,405
+5,592
+2% +$146K 0.9% 33
2024
Q4 		$7.13M Sell
268,813
-41,072
-13% -$1.11M 0.9% 29
2024
Q3 		$8.97M Sell
309,885
-6,247
-2% -$182K 1.04% 23
2024
Q2 		$8.85M Buy
316,132
+10,866
+4% +$299K 1.07% 21
2024
Q1 		$8.47M Buy
305,266
+101,589
+50% +$2.82M 1.01% 23
2023
Q4 		$5.86M Buy
203,677
+39,292
+24% +$1.19M 0.7% 45
2023
Q3 		$5.45M Buy
164,385
+21,566
+15% +$763K 0.68% 43
2023
Q2 		$5.24M Sell
142,819
-7,396
-5% -$288K 0.62% 47
2023
Q1 		$6.13M Sell
150,215
-10,056
-6% -$434K 0.73% 39
2022
Q4 		$8.21M Sell
160,271
-7,595
-5% -$364K 1.17% 25
2022
Q3 		$7.35M Sell
167,866
-1,367
-0.8% -$66.4K 1.1% 30
2022
Q2 		$8.87M Sell
169,233
-7,270
-4% -$370K 1.25% 24
2022
Q1 		$9.14M Sell
176,503
-122,266
-41% -$6.34M 1.12% 29
2021
Q4 		$17.6M Sell
298,769
-3,407
-1% -$169K 1.99% 9
2021
Q3 		$13M Sell
302,176
-7,030
-2% -$311K 1.58% 13
2021
Q2 		$12.1M Buy
309,206
+4,127
+1% +$160K 1.46% 15
2021
Q1 		$11.1M Sell
305,079
-2,183
-0.7% -$77.5K 1.43% 18
2020
Q4 		$11.3M Sell
307,262
-14,117
-4% -$518K 1.51% 17
2020
Q3 		$11.2M Buy
321,379
+6,542
+2% +$229K 1.63% 15
2020
Q2 		$9.77M Buy
314,837
+30,220
+11% +$1.03M 1.55% 16
2020
Q1 		$8.81M Buy
284,617
+8,844
+3% +$301K 1.67% 14
2019
Q4 		$10.3M Sell
275,773
-3,425
-1% -$122K 1.57% 19
2019
Q3 		$9.52M Buy
279,198
+50,446
+22% +$1.83M 1.38% 21
2019
Q2 		$9.4M Buy
228,752
+31,260
+16% +$1.24M 1.42% 21
2019
Q1 		$7.96M Sell
197,492
-6,094
-3% -$244K 1.21% 26
2018
Q4 		$8.43M Sell
203,586
-41,670
-17% -$1.73M 1.41% 22
2018
Q3 		$10.3M Sell
245,256
-4,110
-2% -$158K 1.5% 17
2018
Q2 		$8.58M Buy
249,366
+257
+0.1% +$8.78K 1.34% 22
2018
Q1 		$8.39M Buy
249,109
+32,810
+15% +$1.13M 1.43% 20
2017
Q4 		$7.43M Buy
216,299
+3,426
+2% +$117K 1.17% 31
2017
Q3 		$7.21M Sell
212,873
-2,873
-1% -$92.3K 1.35% 27
2017
Q2 		$6.88M Sell
215,746
-37,138
-15% -$1.17M 1.3% 27
2017
Q1 		$8.21M Sell
252,884
-6,057
-2% -$191K 1.58% 16
2016
Q4 		$7.98M Buy
258,941
+5,965
+2% +$182K 1.61% 17
2016
Q3 		$8.13M Buy
252,976
+7,617
+3% +$255K 1.76% 15
2016
Q2 		$8.2M Buy
245,359
+3,275
+1% +$105K 1.78% 11
2016
Q1 		$6.81M Buy
242,084
+13,759
+6% +$393K 1.56% 15
2015
Q4 		$6.99M Buy
228,325
+542
+0.2% +$17.1K 1.64% 11
2015
Q3 		$6.79M Buy
227,783
+10,029
+5% +$322K 1.68% 10
2015
Q2 		$6.93M Buy
217,754
+4,963
+2% +$162K 1.89% 7
2015
Q1 		$7.02M Buy
212,791
+7,508
+4% +$239K 1.91% 7
2014
Q4 		$6.07M Sell
205,283
-14,897
-7% -$427K 1.68% 15
2014
Q3 		$6.18M Buy
220,180
+5,864
+3% +$165K 1.7% 10
2014
Q2 		$6.04M Buy
214,316
+18,975
+10% +$541K 1.63% 13
2014
Q1 		$5.95M Buy
195,341
+66,343
+51% +$1.98M 1.74% 9
2013
Q4 		$3.75M Sell
128,998
-2,812
-2% -$81.8K 1.1% 33
2013
Q3 		$3.59M Sell
131,810
-1,010
-0.8% -$27.5K 1.18% 32
2013
Q2 		$3.53M Buy
+132,820
New +$3.67M 1.21% 28

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

1834 Investment Advisors's PFE Position: Q2 2026 in Review

1834 Investment Advisors increased its Pfizer (PFE) stake by 0.74% in Q2 2026, buying an estimated $55.8K and bringing the position to 289,830 shares worth $6.98M. The position accounts for 0.79% of the portfolio, ranked #32.

1834 Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.6M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • 1834 Investment Advisors held 289,830 shares of Pfizer worth $6.98M as of Q2 2026.
  • 1834 Investment Advisors bought 2,135 Pfizer shares in Q2 2026, an estimated $55.8K.
  • Pfizer made up 0.79% of 1834 Investment Advisors's portfolio in Q2 2026, its #32 holding.
  • 1834 Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • 1834 Investment Advisors's Pfizer position peaked at $17.6M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on 1834 Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.